C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/02 (2006.01) A61K 39/29 (2006.01) A61P 31/20 (2006.01) A61P 37/04 (2006.01) C07K 1/36 (2006.01)
Patent
CA 2427475
The present invention relates to a method for the production of a hepatitis B antigen suitable for use in a vaccine, the method comprising purification of the antigen in the presence of cysteine, to vaccines comprising such antigens.
La présente invention concerne une technique de production d'antigène d'hépatite B qui convient pour un vaccin. Cette technique consiste à purifier cet antigène en présence de cystéine, pour des vaccins comprenant ces antigènes.
de Heyder Koen
Schu Peter
Serantoni Michelle
Van Opstel Omer
Glaxosmithkline Biologicals S.a. (formerly Known As Smithkline B
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Purification of hbv antigens for use in vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purification of hbv antigens for use in vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purification of hbv antigens for use in vaccines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1343079